CEACAM5 and neoplasm: In clinical settings, prognostic assessment frequently relies on tumor staging systems like the TNM classification, along with serum tumor markers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 (CA19–9) [4].